Healthcare advertising platform PulsePoint has announced the first agency deployment of HCP2DTC Influence™, a marketing solution designed to connect healthcare professional (HCP) insights with direct-to-consumer (DTC) advertising strategies. The inaugural implementation, led by CMI Media Group for an oncology brand, highlights a growing shift toward AI-powered, data-driven healthcare marketing that aligns physician engagement with patient outreach across programmatic advertising channels.

Healthcare marketing platform PulsePoint has introduced the first agency activation of HCP2DTC Influence™, partnering with CMI Media Group to bring physician intelligence into consumer-focused healthcare advertising. The deployment marks an important development in pharmaceutical marketing, where organizations increasingly seek integrated strategies that connect healthcare provider engagement with patient activation across digital channels.

Traditionally, pharmaceutical companies have managed healthcare professional (HCP) and direct-to-consumer (DTC) campaigns as separate initiatives. Physician targeting relies on clinical insights, prescribing behavior, and professional engagement, while consumer campaigns focus on patient awareness and education. This separation has often limited opportunities to coordinate messaging and optimize campaign performance across the healthcare journey.

PulsePoint's HCP2DTC Influence™ platform aims to address this disconnect by enabling pharmaceutical brands to extend insights derived from physician engagement strategies into consumer marketing programs. The result is a unified framework that links HCP intelligence with programmatic DTC activation while maintaining campaign relevance across both audiences.

The first commercial implementation is being executed by CMI Media Group on behalf of a leading oncology brand, making the agency the inaugural partner to operationalize the technology within a live pharmaceutical marketing campaign.

HCP2DTC Influence™ is a healthcare marketing solution that uses healthcare provider intelligence to inform consumer advertising strategies. By connecting physician insights with patient-facing campaigns, the platform enables pharmaceutical marketers to create more coordinated, data-driven engagement across the healthcare ecosystem.

According to PulsePoint, the technology enables brands to leverage existing first-party understanding of healthcare professionals as a strategic input for broader patient engagement initiatives. Rather than operating physician and consumer campaigns independently, marketers can align audience strategies within a unified programmatic framework.

The approach reflects broader changes occurring throughout healthcare marketing as pharmaceutical companies invest more heavily in first-party data, artificial intelligence, and omnichannel engagement platforms. Growing regulatory complexity, evolving privacy requirements, and increased demand for measurable campaign performance have encouraged organizations to consolidate fragmented marketing strategies into integrated technology ecosystems.

CMI Media Group's deployment also illustrates how healthcare agencies are expanding their role beyond campaign execution toward data-driven audience orchestration. As pharmaceutical brands increasingly seek measurable business outcomes, agencies are adopting advanced marketing technologies capable of connecting multiple audience segments while improving media efficiency.

The healthcare marketing sector has become one of the fastest-evolving areas of digital advertising, driven by advances in AI-powered analytics, audience intelligence, and programmatic media buying. According to McKinsey & Company, pharmaceutical organizations continue increasing investment in advanced analytics and AI to improve commercial effectiveness, customer engagement, and marketing decision-making. Gartner likewise identifies AI-enabled marketing platforms as strategic technologies supporting personalized customer experiences and data-driven campaign optimization.

PulsePoint's latest announcement aligns with these trends by extending physician intelligence into broader consumer engagement workflows. Instead of treating HCP and DTC programs as isolated initiatives, the platform encourages coordinated decision-making based on shared audience insights.

The competitive landscape includes healthcare-focused marketing technology providers alongside enterprise platforms from Google, Microsoft, Adobe, and Salesforce, all of which continue expanding AI-powered advertising, customer data, and analytics capabilities. Specialized healthcare marketing platforms differentiate themselves by incorporating industry-specific datasets, regulatory expertise, and healthcare-focused targeting capabilities that general-purpose advertising platforms may not provide.

For pharmaceutical marketing teams, unified HCP and DTC activation has the potential to improve campaign consistency, optimize media investments, and create more connected patient engagement strategies. By aligning physician influence with consumer communications, brands may gain a more comprehensive understanding of how marketing activities contribute to patient awareness and treatment journeys.

Looking ahead, integrated healthcare marketing solutions are expected to play a larger role as pharmaceutical organizations expand omnichannel engagement strategies. The first agency deployment of HCP2DTC Influence™ signals growing industry interest in technologies that bridge traditionally separate marketing functions through AI, first-party data, and programmatic advertising.

Market Landscape

Healthcare marketing is rapidly evolving as pharmaceutical companies adopt AI-powered advertising platforms, first-party data strategies, and omnichannel engagement models. The convergence of healthcare provider intelligence and consumer marketing reflects a broader industry shift toward integrated audience activation, enabling brands to improve personalization, campaign measurement, and cross-channel performance while navigating increasingly complex regulatory requirements.

Top Insights

• PulsePoint and CMI Media Group completed the first commercial deployment of HCP2DTC Influence™, connecting physician intelligence with consumer healthcare advertising.
• The platform helps pharmaceutical marketers align HCP and DTC campaigns using first-party healthcare data within a unified programmatic marketing strategy.
• Integrated healthcare marketing is becoming increasingly important as brands seek measurable performance across physician engagement and patient activation initiatives.
• AI-powered audience intelligence enables healthcare organizations to improve campaign coordination while supporting data-driven media optimization.
• Healthcare agencies are expanding beyond media execution by adopting advanced marketing technologies that unify audience planning across multiple stakeholder groups.

Get in touch with our MarTech Experts